Timothy Van Hauwermeiren

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Tyler Nielsen, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy Van Hauwermeiren:

Company Role Class Num Shares Value Price $ Report Date Ownership
Denali Therapeutics Inc. Director Common Stock 10,632 $154,376 $14.52 04 Nov 2025 Direct
iTeos Therapeutics, Inc. Director Common Stock 22,346 $96,087 $4.30 13 May 2025 Direct
Denali Therapeutics Inc. Director Stock Option (right to buy) 31,897 04 Nov 2025 Direct
Lexeo Therapeutics, Inc. Director Stock Option (right to buy) 22,916 26 Jun 2025 Direct
iTeos Therapeutics, Inc. Director Stock Option (Right to Buy) 0 13 May 2025 Direct
RayzeBio, Inc. Director Stock Option (Right to Buy) 0 26 Feb 2024 Direct

Insider Reports Filed by Timothy Van Hauwermeiren

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DNLI Denali Therapeutics Inc. 04 Nov 2025 2 $0 4 Director 06 Nov 2025, 20:16
DNLI Denali Therapeutics Inc. 04 Nov 2025 0 $0 3 Director 06 Nov 2025, 20:15
LXEO Lexeo Therapeutics, Inc. 26 Jun 2025 1 $0 4 Director 30 Jun 2025, 17:00
ITOS iTeos Therapeutics, Inc. 13 May 2025 2 +$96,088 4 Director 14 May 2025, 20:00
LXEO Lexeo Therapeutics, Inc. 05 Jul 2024 1 $0 4 Director 08 Jul 2024, 18:26
LXEO Lexeo Therapeutics, Inc. 05 Jul 2024 0 $0 3 Director 08 Jul 2024, 18:20
ITOS iTeos Therapeutics, Inc. 11 Jun 2024 1 $0 4 Director 13 Jun 2024, 20:00
RYZB RayzeBio, Inc. 26 Feb 2024 1 $0 4 Director 27 Feb 2024, 17:07
RYZB RayzeBio, Inc. 01 Nov 2023 1 $0 4 Director 01 Nov 2023, 16:09
RYZB RayzeBio, Inc. 01 Nov 2023 0 $0 3 Director 01 Nov 2023, 16:04
ITOS iTeos Therapeutics, Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 19:57
ITOS iTeos Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 19:57
ITOS iTeos Therapeutics, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 20:22